Jason Lettmann, CHIEF EXECUTIVE OFFICER at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 2,230 shares at $1.93 ($4K) on 2026-08-17, disclosed to the SEC on 2026-08-18.
Open-market sale of $4k ALXO by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALXO | SELL | 2025-08-19 | $2K | — | Filing → |
| ALXO | SELL | 2025-02-21 | $2K | — | Filing → |
| ALXO | BUY | 2024-03-18 | $50K | — | Filing → |